10-Sep-2020 | Facts and Factors
Findings from Facts and Factors report “Inhalation Therapy Nebulizer Market by Product (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) & application (COPD, Cystic Fibrosis, Nasal Congestion, Asthma and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Inhalation Therapy Nebulizer market in 2019 was approximately USD 620 Million. The market is expected to grow above a CAGR of 7.6% and is anticipated to reach over USD 1,010 Million by 2026.
Inhalation therapies are a collection of pulmonary or lung therapists, procedures intended to either regain or enhance breathing capacity of patients with different illnesses, disorders or accidents. Inhalation therapy nebulizer is a medical device used for the delivery of the necessary medication in inhalation therapy. When a large dose of an inhalation drug is required it is easy. It is also used in a variety of treatments for medicines such as treating symptoms of asthma and for immediate relief. Compared with MDIs, the nebulizer can be easier to use, especially for small children, babies and anyone who has problems using an asthma inhaler. Nebulizer reduces the risk of the side effects associated with taking high doses of prescribed medicines. The nebulizer is provided for treatment of asthma, cystic fibrosis, bronchitis, common cold, COPD, and other respiratory or illness disorders. On the market, the different types of nebulizer include ultrasonic wave nebulizer, pneumatic nebulizer, and mesh nebulizer.
Browse the full “Inhalation Therapy Nebulizer Market by Product (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) & application (COPD, Cystic Fibrosis, Nasal Congestion, Asthma and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” https://www.fnfresearch.com/inhalation-therapy-nebulizer-market-by-product-pneumatic-nebulizers-1292
The rising incidence of respiratory illness such as chronic obstructive pulmonary disease ( COPD), asthma, obstructive lung diseases around the globe is speeding up the development of the nebulizer market for inhalation therapy. 235 million people globally suffer from asthma according to WHO. Asthma is one of the common chronic respiratory illnesses. The WHO also estimates that by 2030 COPD will become the world's third leading cause of death. Nebulizers are commonly used in the treatment of respiratory conditions due to its advantages such as ease of use relative to an inhaler's dried powder. In addition, the air pollution across the globe and the geriatric population with multiple diseases help factor driving growth of the demand for nebulizer inhalation therapy. On the other hand, one of the major issues could hamper the growth of the demand for nebulizer inhalation therapy is the possibility of drug loss caused by nebulizer during the delivery of the medication into the mist. Furthermore, it is expected that the use of nebulizer inhalation therapy in other diseases such as diabetes and migraine would create growth opportunities for the demand for nebulizer inhalation therapy.
The Inhalation Therapy Nebulizer market is segmented into product, application and region segment. The product segment is segmented into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers. The application segment is fragmented into COPD, Cystic Fibrosis, Nasal Congestion, Asthma and Others.
Geographically, North America accounted for the largest share of the global demand for nebulizer inhalation therapy across the region. High COPD and asthma incidence in adults and children raise U.S. demand for inhalation therapy nebulizers. In addition, well-developed healthcare infrastructures and technical advancements are some factors that fuel consumer demand in the North American region. In the forecast timeframe Europe is projected to see significant growth in the demand for inhalation therapy nebulizers. Some factors driving the demand for inhalation therapy nebulizer market in the Europe region during the forecast period are increasing awareness of the use of nebulizers and favourable health policies.
Top key players operating in the market 3M, AptarGroup, Inc., Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., OMRON Corporation, DeVilbiss Healthcare LLC, PARI GmbH Spezialisten für effektive Inhalation, Air Liquide Medical Systems, A&D Company, GF HEALTH PRODUCTS, INC., Vyaire Medical Inc., and Trudell Medical International amongst others.
This report segments the Inhalation Therapy Nebulizermarket as follows:
Global Inhalation Therapy Nebulizers Market: Product Type Segment Analysis
- Pneumatic Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
Global Inhalation Therapy Nebulizers Market: Application Segment Analysis
- Cystic Fibrosis
- Nasal Congestion
Global Inhalation Therapy NebulizerMarket: Regional Segmentation Analysis
- North America
- The UK
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
A 2108, Sargam,
Pune 411041, India
Email: [email protected]